Skip to content

HELIX BIOMEDIX INC

CIK 0000831749

← back to feed
Revenue (TTM)
$2.01M
+122.1% YoY Q3 Oct 2012
Net Income (TTM)
−$2.64M
+67.7% YoY Q3 Oct 2012
EPS Diluted (TTM)
−$0.05
+82.1% YoY Q3 Oct 2012
Gross Margin
68.4%
Q3 Oct 2012
Operating Margin
-122.6%
Q3 Oct 2012
Net Margin
-131.1%
Q3 Oct 2012
Free Cash Flow (TTM)
−$2.3M
Q3 Oct 2012
Cash
$216.53K
Q3 Oct 2012
Total Debt
—
Q3 Oct 2012
Shares Outstanding
49.72M sh
Q3 Oct 2012

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings